Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Tamarack Advisers

Latest statistics and disclosures from Tamarack Advisers's latest quarterly 13F-HR filing:

Top 5 stock holdings are SPY, TLT, MDRX, VTRS, PHR, and represent 69.58% of Tamarack Advisers's stock portfolio.
Added to shares of these 10 stocks: SPY (+$175M), TLT (+$15M), BMRN (+$6.5M), ABT, MCK, BDX, TEVA, ATRC, DXCM, MDRX.
Started 9 new stock positions in SPY, SPB, BDX, TEVA, BMRN, ABT, Kenvue, TLT, DXCM.
Reduced shares in these 10 stocks: Powershares Qqq Etf Put Opt 01/19 154.0 put (-$80M), , Invesco Exchange Traded Fd T call (-$15M), AMGN (-$7.3M), DCGO, Teladoc Inc put, , VTRS, RDNT, ASND.
Sold out of its positions in AMGN, ASND, FENC, ICUI, Powershares Qqq Etf Put Opt 01/19 154.0 put, Invesco Exchange Traded Fd T call, MXCT, NSTG, NEOG, PCRX. Spdr S&p 500 Etf Tr option, SEM, SLGCW, Teladoc Inc put, Tenet Healthcare Corp call, UTHR.
Tamarack Advisers was a net buyer of stock by $45M.
Tamarack Advisers has $324M in assets under management (AUM), dropping by 18.26%.
Central Index Key (CIK): 0001661462

Tip: Access up to 7 years of quarterly data

Positions held by Tamarack Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Tamarack Advisers

Tamarack Advisers holds 32 positions in its portfolio as reported in the June 2023 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
SPDR S&P 500 ETF Trust Jul3 425.0 P Listed Option Put Option (SPY)	54.2	$175M	NEW	400k	438.11	View chart
iShares 20 Plus Year Treasury Bond ETF Sep3 110.0 C Listed Option Call Option (TLT)	4.8	$15M	NEW	150k	102.94	View chart
Veradigm Inc Jul3 10.0 C Listed Option Call Option (MDRX)	4.0	$13M	+8%	1.0M	12.60	View chart
Viatris Ord Equity (VTRS)	3.9	$13M	-16%	1.3M	9.98	View chart
Phreesia Ord Equity (PHR)	2.8	$9.0M	-9%	290k	31.01	View chart
Collegium Pharmaceutical Ord Equity (COLL)	2.5	$8.1M	+5%	375k	21.49	View chart
Tenet Healthcare Ord Equity (THC)	2.4	$7.7M	-5%	95k	81.38	View chart
Tactile Systems Technology Ord Equity (TCMD)	2.3	$7.5M	-16%	300k	24.93	View chart
Biomarin Pharmaceutical Ord Equity (BMRN)	2.0	$6.5M	NEW	75k	86.68	View chart
Streamline Health Solutions Ord Equity (STRM)	1.9	$6.3M		4.9M	1.27	View chart
Mckesson Ord Equity (MCK)	1.8	$6.0M	+366%	14k	427.31	View chart
Si Bone Ord Equity (SIBN)	1.7	$5.4M	-27%	200k	26.98	View chart
Sanofi Adr Rep 1 1/2 Ord Equity (SNY)	1.6	$5.1M		95k	53.90	View chart
Abbott Laboratories Ord Equity (ABT)	1.5	$4.9M	NEW	45k	109.02	View chart
Angiodynamics Ord Equity (ANGO)	1.5	$4.8M	-2%	465k	10.43	View chart
Radnet Ord Equity (RDNT)	1.4	$4.6M	-33%	140k	32.62	View chart
Cerus Ord Equity (CERS)	1.3	$4.3M	-22%	1.8M	2.46	View chart
Atricure Ord Equity (ATRC)	1.3	$4.2M	+110%	85k	49.36	View chart
Becton Dickinson Ord Equity (BDX)	1.2	$4.0M	NEW	15k	264.01	View chart
Teva Pharma Ind Adr Rep 1 Ord Equity (TEVA)	1.0	$3.4M	NEW	450k	7.53	View chart
Alkermes Ord Equity (ALKS)	1.0	$3.1M	+33%	100k	31.30	View chart
Inmode Ord Equity (INMD)	0.9	$2.8M	-34%	75k	37.35	View chart
Ironwood Pharma Cl A Ord Equity (IRWD)	0.7	$2.4M	+7%	225k	10.64	View chart
Dexcom Ord Equity (DXCM)	0.6	$2.1M	NEW	16k	128.51	View chart
Rigel Pharmaceuticals Ord Equity (RIGL)	0.5	$1.6M	-37%	1.3M	1.29	View chart
Docgo Ord Equity (DCGO)	0.4	$1.3M	-77%	135k	9.37	View chart
Spectrum Brands Holdings Ord Equity (SPB)	0.2	$781k	NEW	10k	78.05	View chart
Bio Rad Laboratories Cl A Ord Equity (BIO)	0.2	$758k	+100%	2.0k	379.12	View chart
Bio Techne Ord Equity (TECH)	0.1	$327k	+300%	4.0k	81.63	View chart
Somalogic Cl A Ord Equity (SLGC)	0.1	$300k	-72%	130k	2.31	View chart
Olink Holding Ab Publ Equity (OLK)	0.1	$281k	-47%	15k	18.75	View chart
Kenvue Ord Equity	0.0	$26k	NEW	1.0k	26.42	View chart

Past Filings by Tamarack Advisers

SEC 13F filings are viewable for Tamarack Advisers going back to 2015

Tamarack Advisers 2023 Q2 filed Aug. 10, 2023
Tamarack Advisers 2023 Q1 filed May 11, 2023
Tamarack Advisers 2022 Q4 filed Feb. 13, 2023
Tamarack Advisers 2022 Q3 filed Nov. 15, 2022
Tamarack Advisers 2022 Q2 filed Aug. 16, 2022
Tamarack Advisers 2022 Q1 filed May 11, 2022
Tamarack Advisers 2021 Q4 filed Feb. 14, 2022
Tamarack Advisers 2021 Q3 filed Nov. 12, 2021
Tamarack Advisers 2021 Q2 filed Aug. 13, 2021
Tamarack Advisers 2021 Q1 filed May 12, 2021
Tamarack Advisers 2020 Q4 filed Feb. 10, 2021
Tamarack Advisers 2020 Q3 filed Nov. 12, 2020
Tamarack Advisers 2020 Q2 filed Aug. 11, 2020
Tamarack Advisers 2020 Q1 filed May 14, 2020
Tamarack Advisers 2019 Q4 filed Feb. 11, 2020
Tamarack Advisers 2019 Q3 filed Nov. 5, 2019

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z